S&P 500

6.021,63

0,57%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

BNT

Basepoint (BNT)

Basepoint

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:LSE:BNT

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/11/2005	09:14	UK Regulatory	Compulsory Acqn of Shares	LSE:BNT	Basepoint
04/11/2005	09:45	UK Regulatory	Directorate Change	LSE:BNT	Basepoint
04/11/2005	05:00	UK Regulatory	Issue of Equity	LSE:BNT	Basepoint
31/10/2005	07:46	UK Regulatory	Interim Results	LSE:BNT	Basepoint
31/10/2005	06:39	UK Regulatory	Cancellation of trade on AIM	LSE:BNT	Basepoint
31/10/2005	05:00	UK Regulatory	Offer Update	LSE:BNT	Basepoint
28/10/2005	10:17	UK Regulatory	Rule 8.1- Basepoint plc	LSE:BNT	Basepoint
27/10/2005	10:01	UK Regulatory	Notice of Results	LSE:BNT	Basepoint
10/10/2005	07:27	UK Regulatory	EPT Disclosure	LSE:BNT	Basepoint
10/10/2005	05:48	UK Regulatory	Offer Document Posted	LSE:BNT	Basepoint
07/10/2005	06:43	UK Regulatory	Offer by ACG	LSE:BNT	Basepoint
21/09/2005	06:54	UK Regulatory	Director/PDMR Shareholding	LSE:BNT	Basepoint
20/07/2005	07:59	UK Regulatory	AGM Statement	LSE:BNT	Basepoint
26/05/2005	07:27	UK Regulatory	Final Results	LSE:BNT	Basepoint
08/02/2005	05:02	RNS Non-Regulatory	New MBEC at Swindon	NYSE:BNT	Basepoint Plc
17/01/2005	12:12	RNS Non-Regulatory	SEEDA Ent Gateway Contract	NYSE:BNT	Basepoint Plc
01/12/2004	14:56	UK Regulatory	Dir Shareholding - Amendment	LSE:BNT	Basepoint
01/12/2004	09:34	UK Regulatory	Director Shareholding	LSE:BNT	Basepoint
26/11/2004	11:56	RNS Non-Regulatory	Bournemouth Business Centre	NYSE:BNT	Basepoint Plc
11/10/2004	09:53	UK Regulatory	Opening New Business Centre	LSE:BNT	Basepoint
07/09/2004	04:00	UK Regulatory	Breakdown of Negotiations	LSE:BNT	Basepoint
28/07/2004	09:00	PR Newswire (US)	Bentley Pharmaceuticals Reports Record Revenues in Second Quarter of 2004	NYSE:BNT
21/07/2004	09:00	PR Newswire (US)	Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004	NYSE:BNT
21/06/2004	09:00	PR Newswire (US)	Bentley Pharmaceuticals Receives Approval to Market Generic Versions of the Gastrointestinal Product, Lansoprazole, in Spain	NYSE:BNT
14/06/2004	09:07	RNS Non-Regulatory	First SEEDA Project - Gosport	NYSE:BNT	Basepoint Plc
08/06/2004	09:00	PR Newswire (US)	Bentley Pharmaceuticals Elects Two New Directors and Adjourns Annual Stockholders' Meeting	NYSE:BNT
24/05/2004	11:46	PR Newswire (US)	Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference	NYSE:BNT
18/05/2004	12:35	PR Newswire (US)	Bentley Pharmaceuticals Receives Approval to Market a Generic Version of Simvastatin in The U.K.	NYSE:BNT
12/05/2004	11:35	PR Newswire (US)	Bentley Pharmaceuticals Begins Trading on the New York Stock Exchange	NYSE:BNT
21/04/2004	04:01	UK Regulatory	Holding(s) in Company	LSE:BNT	Basepoint